DNA · trading date Oct 12, 2026 · previous close $13.01 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$170.16M
Net income
-$312.76M
Total assets
$1.12B
Total liabilities
$611.11M
Stockholders' equity
$508.59M
Cash & equivalents
$167.20M
Operating income
-$315.28M
Operating cash flow
-$171.06M
Capital expenditures
$7.67M
Fiscal year 2025, via 10-K filed 2026-02-26.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-185.3%
Net margin
-183.8%
Free cash flow
-$178.72M
Free cash flow margin
-105.0%
Liabilities / assets
54.6%
Equity / assets
45.4%
CapEx / revenue
4.5%
Operating cash flow / net income
0.55×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Boston, MA 02210
27 DRYDOCK AVENUE
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:35 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.